Topics

Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria

08:00 EST 27 Dec 2019 | Genetic Engineering News

MDR pathogenic bacteria are an emerging threat to human life globally. Engineered phage therapy could play an important future role treating highly resistant pathogens, due to the orthogonal route of attack by phage compared with traditional small molecule therapies. High-throughput phage engineering facilitated by biofoundries is needed to create repositories of clinical-grade phage to treat the most serious AMR cases across the globe.

The post Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria appeared first on GEN - Genetic Engineering and Biotechnology News.

Original Article: Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria

NEXT ARTICLE

More From BioPortfolio on "Building Better Bacteriophage with Biofoundries to Combat Antibiotic-Resistant Bacteria"

Quick Search